A comparison of risk factors associated with community-associated methicillin-resistant and -susceptible Staphylococcus aureus infections in remote communities

Epidemiology and Infection

Volumn 138, Issue 5, 2010, Pages 730-737

  Golding, G R ^a   Levett, P N ^b   McDonald, R R ^b   Irvine, J ^c   Nsungu, M ^d   Woods, S ^d   Horbal, A ^e   Siemens, C G ^e   Khan, M ^f   Ofner Agostini, M ^g   Mulvey, M R ^a,e  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Saskatchewan Disease Control Laboratory   (Canada)

^c Population Health Unit   (Canada)

^d Northern Intertribal Health Authority   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f Kelsey Trail Health Region   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Bacterial infections; Bacterial typing; Community outbreaks; Methicillin resistant S. aureus (MRSA); Staphylococcus aureus

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; MACROLIDE; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; COMMUNITY ASSOCIATED METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS INFECTION; CROWDING; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFANT; INFECTION RISK; INSECT BITE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SKIN DISEASE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; CASE CONTROL STUDY; COMMUNICABLE DISEASE; DRUG EFFECT; DRUG UTILIZATION; FAMILY HEALTH; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; RISK FACTOR; STAPHYLOCOCCAL SKIN INFECTION; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROWDING; DRUG UTILIZATION; FAMILY HEALTH; FEMALE; HUMANS; INFANT; INSECT BITES AND STINGS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 77950893391     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809991488     Document Type: Article

References (35)

1. Low DE, et al. Methicillin-resistant Staphylococcus aureus-Ontario. Canadian Disease Weekly Report 1981; 7: 249-250.
2. Simor AE, et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals : 5 years of national surveillance. Canadian Medical Association Journal 2001; 165: 21-26.
3. Simor AE, et al. Laboratory characterization of methicillin- resistant Staphylococcus aureus in Canadian hospitals : Results of 5 years of national surveillance, 1995-1999. Journal of Infectious Diseases 2002; 186: 652-660.
4. Aiello AE, et al. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infectious Diseases 2006; 6: 335-341.
5. Al-Rawahi GN, et al. Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users : six years later. Journal of Clinical Microbiology 2008; 46: 477-479.
6. Benjamin HJ, Nikore V, Takagishi J. Practical management: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): the latest sports epidemic. Clinical Journal of Sports Medicine 2007; 17: 393-397.
7. Gilbert M, et al. Outbreak in Alberta of communityacquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. Canadian Medical Association Journal 2006; 175: 149-154.
8. Lo WT, et al. Nasal carriage of a single clone of community- acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan. BMC Infectious Diseases 2007; 7: 51.
9. Main CL, et al. Outbreaks of infection caused by community- acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Canadian Journal of Infectious Diseases and Medical Microbiology 2005; 16: 343-348.
10. Mulvey MR, et al. Community-associated methicillinresistant Staphylococcus aureus, Canada. Emerging Infectious Diseases 2005; 11: 844-850.
11. Ofner-Agostini M, et al. Methicillin-resistant Staphylococcus aureus in Canadian aboriginal people. Infection Control and Hospital Epidemiology 2006; 27: 204-207.
12. Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Canadian Communicable Disease Report 2007; 33: 45-48.
13. Castaldo ET, Yang EY. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus : An emerging fatal problem. The American Surgeon 2007; 73: 684-688.
14. Vayalumkal JV, et al. Necrotizing pneumonia and septic shock: Suspecting CA-MRSA in patients presenting to Canadian emergency departments. Journal of the Canadian Association of Emergency Physicians 2007; 9: 300-303.
15. Seybold U, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clinical Infectious Diseases 2006; 42: 647-656.
16. D'Agata EM, et al. Modeling the invasion of community- acquired methicillin-resistant Staphylococcus aureus into hospitals. Clinical Infectious Diseases 2009; 48: 274-284.
17. Embil J, et al. Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infection Control and Hospital Epidemiology 1994; 15: 646-651.
18. Shahin R, et al. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto child care center study group. Archives of Pediatric and Adolescent Medicine 1999; 153: 864-868.
19. Christianson S, et al. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2007; 45: 1904-1911.
20. Al-Rawahi GN, et al. Community-associated CMRSA- 10 (USA-300) is the predominant strain among methicillin- resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital. Journal of Emergency Medicine. Published online : 4 March 2008. doi:10.1016/j.jemermed.2007. 09.030.
21. Kurbis AC, Wylie JL. Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Canadian Journal of Infectious Diseases 2001; 12: 149-152.
22. Wylie JL, Nowicki DL. Molecular epidemiology of community- and health care-associated methicillinresistant Staphylococcus aureus in Manitoba, Canada. Journal of Clinical Microbiology 2005; 43: 2830-2836.
23. Irvine J, et al. Dissemination of community-associated methicillin-resistant Staphylococcus aureus CMRSA7 (USA400) in northern Saskatchewan, Canada. Sixth International Conference on Emerging Infectious Diseases, 16-19 March 2008, Atlanta, Georgia.
24. Dalloo A, et al. Investigation of community-associated methicillin-resistant Staphylococcus aureus in a remote northern community, Nunavut, Canada. Canadian Communicable Disease Report 2008; 34: 1-7.
25. McDonald RR, et al. Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillinresistant Staphylococcus aureus. Journal of Clinical Microbiology 2005; 43: 6147-6149.
26. Naimi TS, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Journal of the American Medical Association 2003; 290: 2976-2984.
27. Mulvey MR, et al. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. Journal of Clinical Microbiology 2001; 39: 3481-3485.
28. Harmsen D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of Clinical Microbiology 2003; 41: 5442-5448.
29. Anthony RM, et al. Use of the polymerase chain reaction for rapid detection of high-level mupirocin resistance in staphylococci. European Journal of Clinical Microbiology and Infectious Diseases 1999; 18: 30-34.
30. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptiblity testing ; 17th informational supplement. CLSI document M100-S17. Clincal and Laboratory Standards Institute, 2007. Wayne, PA.
31. Skov R, Frimodt-Moller N, Espersen F. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagnostic Microbiology and Infectious Diseases 2001; 40: 111-116.
32. Walker ES, et al. A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions. Journal of Clinical Microbiology 2004; 42: 2792-2795.
33. Golding GR, et al. A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typing. Canadian Journal of Infectious Disease and Medical Microbiology 2008; 19: 273-281.
34. Bocher S, et al. Methicillin-resistant Staphylococcus aureus : risk factors associated with community-onset infections in Denmark. Clinical Microbiology and Infection 2008; 14: 942-948.
35. Romano R, Lu D, Holtom P. Outbreak of communityacquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. Journal of Athletic Training 2006; 41: 141-145.